The objectives of this application are (a) to provide the candidate with further training and experience in several research techniques which will not only enhance the present investigations but also provide a broad base from which the candidate may pursue his long term goals in the study of mental illness, and (b) to investigate in further detail three separate but related aspects of certain """"""""excitotoxic"""""""" molecules which are structurally and pharmacologically similar to the putative mammalian neurotransmitter glutamic acid (Glu). Several lines of evidence suggest that Glu [and/or aspartic acid (Asp)] is the excitatory transmitter in many brain regions, including some major pathways in the """"""""limbic system."""""""" In the last few years the potent Glu agonist kainic acid (KA) has been used as an axon-sparing lesioning tool to study structure-function relationships within the CNS. Other Glu agonists such as N-methyl aspartic acid (NMA) may be equally, if not better suited for such studies. Recently it has been demonstrated by the candidate that the neurotoxic activity of KA can be enhanced by morphine and suppressed by diazepam, suggesting an interaction between the glutamergic system and psychoactive drugs which are significantly involved in both therapy and abuse. A major focus of this proposal is to study the mechanism(s) underlying this interaction. In addition to a variety of neurohistologic approaches to be used in these studies, the candidate will learn and employ the neurochemical techniques used to investigate high-affinity uptake and receptor bindings. *Other investigators have reported an age-dependent susceptibility of striatal neurons to the toxic action of KA, concluding that a mature and intact glutamergic pathway is required for this toxin to be effective. The applicant proposes to study the toxic effect of Glu, KA and other Glu analogs in relation to the development of specific pathways in rat brain. The olfactory cortex and other limbic areas will be focused upon with systemic administration as well as direct injection of these """"""""excitotoxic"""""""" amino acids. During the implementation of these studies the applicant will learn methods of autoradiography in order to

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01MH000330-05
Application #
3068617
Study Section
Research Scientist Development Review Committee (MHK)
Project Start
1981-04-01
Project End
1986-03-31
Budget Start
1985-04-01
Budget End
1986-03-31
Support Year
5
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Washington University
Department
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Huey, Edward D; Mirza, Nadeem; Putnam, Karen T et al. (2006) Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients. Dement Geriatr Cogn Disord 22:48-53
Sunderland, Trey; Hampel, Harald; Takeda, Masatoshi et al. (2006) Biomarkers in the diagnosis of Alzheimer's disease: are we ready? J Geriatr Psychiatry Neurol 19:172-9
Filbey, Francesca M; Slack, Kelly J; Sunderland, Trey P et al. (2006) Functional magnetic resonance imaging and magnetoencephalography differences associated with APOEepsilon4 in young healthy adults. Neuroreport 17:1585-90
Sunderland, Trey; Gur, Raquel E; Arnold, Steven E (2005) The use of biomarkers in the elderly: current and future challenges. Biol Psychiatry 58:272-6
Sunderland, Trey (2005) Geriatric psychiatry: coming of age in America. Biol Psychiatry 58:263-4
Sunderland, Trey; Mirza, Nadeem; Putnam, Karen T et al. (2004) Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Biol Psychiatry 56:670-6
Ray, J P; Russchen, F T; Fuller, T A et al. (1992) Sources of presumptive glutamatergic/aspartatergic afferents to the mediodorsal nucleus of the thalamus in the rat. J Comp Neurol 320:435-56
Carnes, K M; Fuller, T A; Price, J L (1990) Sources of presumptive glutamatergic/aspartatergic afferents to the magnocellular basal forebrain in the rat. J Comp Neurol 302:824-52
Fuller, T A; Price, J L (1988) Putative glutamatergic and/or aspartatergic cells in the main and accessory olfactory bulbs of the rat. J Comp Neurol 276:209-18
Fuller, T A; Russchen, F T; Price, J L (1987) Sources of presumptive glutamergic/aspartergic afferents to the rat ventral striatopallidal region. J Comp Neurol 258:317-38

Showing the most recent 10 out of 11 publications